de Zegher F.
Endocrinology Unit, Hospital
Sant Joan de Deu, University of Barcelona, Passeig de Sant Joan
de Deu 2, 08950 Esplugues, Barcelona, Spain. libanez@hsjdbcn.org
Context andObjectives:
Girls with precocious pubarche (PP, pubic hair at< 8 yr of age) are at high
risk for early onset and rapid progression of puberty, in particular if their
prenatal growth was restrained, i.e. low birth weight (LBW), and followed by
rapid postnatal catch-up of weight gain. We postulated that insulin resistance
contributes to early onset and rapid progression of puberty in LBW-PP girls and
thus explored the puberty-delaying effects of insulin sensitization with
metformin initiated shortly after PP diagnosis.
Settings,
Design and Patients:
The study population consisted of 38 prepubertal LBW girls
with PP attributed to exaggerated adrenarche [mean body
weight, 2.4 kg; age, 7.9 yr; body mass index (BMI), 18.4
kg/m(2)]. These girls were randomly assigned to remain
untreated (n = 19) or to receive metformin (n = 19; 425
mg/d) for 2 yr.
Settings, Design and Main Outcome Measures:
Pubertal staging, age at menarche, body composition by absorptiometry,
fasting insulin, glucose, lipids, leptin, IGF-I, IGF-binding protein-1,
testosterone, dehydroepiandrosterone sulfate, and SHBG were the main outcome
measures.
Results:
Metformin treatment was associated with a less adipose body composition (and
lower serum leptin levels) and with a 0.4-yr delay in the clinical onset of
puberty (Tanner B2; 9.5 vs. 9.1 yr; P< 0.01). These findings were corroborated
by a delay of at least 1 yr in the puberty-associated rise of circulating IGF-I
(P< 0.01). Available results also point to a metformin-associated delay of
menarche (P< 0.02). Gain in height and lean mass was not divergent between study
subgroups.
Conclusion:
The efficacy of early metformin treatment in PP girls is here
extended to include not only a less adipose body composition
after 2 yr but also a less advanced onset of puberty, whereas
height gain is maintained. These findings open the perspective
that, ultimately, metformin treatment may also prove to heighten
the short adult stature of LBW-PP girls.
Related Medical Abstracts - Click on the paper
title:-
